Green Space Exposure in Pregnancy, Early Childhood May Cut Risk for Neurodevelopmental Disorders
By Lori Solomon HealthDay Reporter
TUESDAY, July 29, 2025 -- Living near green spaces before and during pregnancy, as well as in early childhood, may lower the risk for neurodevelopmental disorders, according to a study published in the August issue of Environment International.
Hayon Michelle Choi, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a population-based cohort study to examine the link between exposure to green space before, during, and after pregnancy and neurodevelopmental delays in children. The analysis included approximately 1.85 million mother-child pairs identified from the Medicaid Analytic Extract (2001 to 2014), with up to 14 years of follow-up.
The researchers found protective associations between green space exposure and most neurodevelopmental disorders. Per interquartile range increase in the Normalized Difference Vegetation Index, the strongest associations were seen for preconception exposure and intellectual disability (hazard ratio [HR], 0.66), pregnancy exposure and autism spectrum disorder (HR, 0.83), and postnatal exposure for learning difficulties (HR, 0.81). The protective effects were stronger for Black/Hispanic children and for those living in urban areas.
"These findings suggest that increasing green space access could be a potentially modifiable environmental strategy to reduce the risk of neurodevelopmental disorders among children, especially in vulnerable, low-income populations," senior author Stefania Papatheodorou, M.D., Ph.D., also from Harvard, said in a statement. "It also suggests that urban planning strategies that enhance residential greenness may have long-term developmental benefits for children."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
MONDAY, July 28, 2025 -- Despite a shift from valproate to safer antiseizure medications (ASMs) in pregnancy, many medications with known or uncertain risks are still being...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.